Avidity Partners Management LP Uni Qure N.V. Transaction History
Avidity Partners Management LP
- $885 Million
- Q4 2024
A detailed history of Avidity Partners Management LP transactions in Uni Qure N.V. stock. As of the latest transaction made, Avidity Partners Management LP holds 222,000 shares of QURE stock, worth $2.85 Million. This represents 0.44% of its overall portfolio holdings.
Number of Shares
222,000
Previous 673,618
67.04%
Holding current value
$2.85 Million
Previous $3.32 Million
18.07%
% of portfolio
0.44%
Previous 0.2%
Shares
6 transactions
Others Institutions Holding QURE
# of Institutions
171Shares Held
42.5MCall Options Held
2.61MPut Options Held
582K-
Eco R1 Capital, LLC San Francisco, CA3.4MShares$43.7 Million2.81% of portfolio
-
Vestal Point Capital, LP New York, NY3.03MShares$38.8 Million3.17% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.45MShares$31.5 Million2.18% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.18MShares$27.9 Million0.56% of portfolio
-
Franklin Resources Inc San Mateo, CA1.99MShares$25.5 Million0.01% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $600M
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...